rs372681462
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_022340.4(RBSN):c.2060C>T(p.Pro687Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000415 in 1,613,932 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_022340.4 missense
Scores
Clinical Significance
Conservation
Publications
- congenital neutropenia-myelofibrosis-nephromegaly syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152040Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251250 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.0000451 AC: 66AN: 1461892Hom.: 0 Cov.: 32 AF XY: 0.0000330 AC XY: 24AN XY: 727248 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152040Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74254 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2060C>T (p.P687L) alteration is located in exon 14 (coding exon 11) of the RBSN gene. This alteration results from a C to T substitution at nucleotide position 2060, causing the proline (P) at amino acid position 687 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at